Vijay Kunadian
Member of the Editorial Team, PCRonline Editorial Board
Declaration of interest
| Function | Company |
|---|---|
| Honorarium | Bayer |
| Honorarium | AstraZeneca |
| Honorarium | Abbott Vascular |
| Grants/research support | AstraZeneca |
Latest contributions
New evidence in coronary physiology for microvascular assessment
21 May 2026 – From EuroPCR 2026
This session highlights new evidence in coronary physiology related to microvascular assessment. Topics include endothelial dysfunction in angina with non-obstructive arteries, the prognostic value of microvascular resistance metrics, natural history studies, and trials aimed at standardizing management of microvascular dysfunction.
Hybrid percutaneous revascularisation: combining DES and DCB for optimal results
21 May 2026 – From EuroPCR 2026
This session delves into hybrid percutaneous revascularisation techniques that combine drug-eluting stents (DES) and drug-coated balloons (DCB) to achieve optimal clinical results. It highlights the clinical and anatomical scenarios suited for hybrid PCI, provides a step-by-step procedural approach, and discusses the potential benefits of integrating these...
Diagnosis and management of INOCA and ANOCA
21 May 2026 – From EuroPCR 2026
This session focuses on the diagnosis and management of ischemia and angina with non-obstructive coronary arteries (INOCA and ANOCA). It presents safety data from coronary function testing, patient outcomes after comprehensive ischemia assessment, and endotype-specific treatment effects. Further topics include coronary sinus reducer therapy, the impact...
Beyond the diagnosis: a qualitative exploration of women’s experiences with cardiovascular disease
21 May 2026 – From EuroPCR 2026
This session presents a qualitative exploration of women's experiences with cardiovascular disease, highlighting unique challenges throughout their care pathway from diagnosis to rehabilitation. It shares robust patient experience data and offers recommendations aimed at improving cardiovascular care tailored to women’s specific needs.
Typical chest pain: atypical angiogram
20 May 2026 – From EuroPCR 2026
This session addresses the management challenges posed by acute coronary syndromes when angiographic findings are ambiguous or atypical. It highlights the role of intravascular imaging in clarifying diagnoses and discusses recent insights from clinical cases and key studies such as DISCO and the latest NSTEMI EuroIntervention...
STEMI 2026 - The precision revolution
19 May 2026 – From EuroPCR 2026
Explore the forefront of STEMI care with a focus on precision medicine, integrating artificial intelligence for pre-hospital triage, evidence-based complete revascularisation strategies, and advanced imaging guidance during primary PCI. This session also addresses tailored antithrombotic approaches, timing of mechanical support in cardiogenic shock, and management of...
All about PCR’s Teaching Assessment Board (TAB)
03 Dec 2025
Learn how session feedback is compiled to create a virtuous cycle of continuous refinement for education in #interventionalcardiology
Learning from lived experience and contemporary evidence: shaping the treatment of women with heart valve disease
17 Nov 2025 – From PCR London Valves 2025
This session provides an in-depth exploration of the lived experiences of women with valvular heart disease, emphasizing the unique challenges in detection, diagnosis, treatment, and follow-up. It integrates contemporary evidence and the forthcoming 2025 ESC/EACTS guidelines to offer practice-ready strategies tailored to the management of valvular...
PCI for complex bifurcation disease - LIVE Case
23 May 2025 – From EuroPCR 2025
A 60-year-old male patient presented with an inferior STEMI one month ago, which was treated with RCA and LCx PCI. He was referred for LAD/diagonal PCI. The LV function was reduced (EF 45 %). The team performed a DK crush PCI, guided by IVUS.
LIVE Educational Case...
Which device for which patient: DES, BRS or DCB?
22 May 2025 – From EuroPCR 2025
This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.
ACS with normal coronary arteries: angiography done, job done?
21 May 2025 – From EuroPCR 2025
Understand the clinical significance of MINOCA and learn diagnostic strategies integrating invasive and non-invasive tests to identify underlying etiologies. This session provides therapeutic insights tailored to specific MINOCA endotypes through illustrative cases.
Contemporary challenges in acute coronary syndromes
20 May 2025 – From EuroPCR 2025
Examine contemporary challenges in acute coronary syndromes (ACS) through recent trials and studies. Topics include long-term outcomes of deferred stenting, thrombectomy techniques, PCI in cardiogenic shock, and revascularisation strategies, providing a comprehensive update for clinical practice.
How to implement the diagnosis of INOCA in everyday practice?
20 May 2025 – From EuroPCR 2025
In this exchange, Vijay Kunadian and Javier Escaned explore the real-world implementation of INOCA (Ischemia with Non-Obstructive Coronary Arteries) and ANOCA (Angina with Non-Obstructive Coronary Arteries) diagnostic pathways. Drawing on the 2024 CCS (Chronic Coronary Syndromes) guidelines, and the EAPCI consensus document, they discuss why these...
TAVI in women - Recent trials and current understanding
25 Nov 2024 – From PCR London Valves 2024
Looking to learn more about gender-based differences in the presentation and management of aortic stenosis? Dont' miss this video on the specifics of TAVI in women!
You'll discover how aortic stenosis presents uniquely in female patients, review the latest data on TAVI outcomes in women, and gain...
Update on coronary physiology in 2024
17 May 2024 – From EuroPCR 2024
This session provides an update on the available options for invasive coronary physiology in 2024. It reviews the latest evidence supporting the clinical adoption of invasive physiology indexes and shares practical tips and tricks for their application. Topics covered include CT-based physiology, pressure wire-based physiology, angiography-based...
Role of PCI in the contemporary management of patients with angina and coronary disease
17 May 2024 – From EuroPCR 2024
This session aims to generate awareness about the distinct phenotypes of coronary artery disease (focal, diffuse, serial) that can be identified through contemporary physiological tools, and the implications of these phenotypes on achieving successful functional PCI results. Participants will also discuss the considerations around using PCI...
Multivessel disease PCI guided by physiology and IVUS - LIVE case
16 May 2024 – From EuroPCR 2024
A 78-year-old woman with hypertension, dyslipidemia, and obesity, presented with angina CCS2 and preserved LV function. The coronary angiogram showed stenosis in the RCA (proximal and mid), CX, and calcified proximal and mid LAD involving D1 and D2.
The operators performed PCI on the RCA (1 stent)...
Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration
16 May 2024 – From EuroPCR 2024
In this session, learn how to advance heart team collaboration through optimized TAVI pre-work-up and refined severe aortic stenosis patient selection, ensuring accurate intervention indications. Gain hands-on insights for effective post-TAVI strategies, explore procedural and valve refinements that simplify post-TAVI PCI, and stay informed on the...
Management of MINOCA patients
15 May 2024 – From EuroPCR 2024
Management of patient with coronary artery disease and left ventricle dysfunction
15 May 2024 – From EuroPCR 2024
This session focuses on the management of patients with stable coronary artery disease and left ventricular dysfunction. Experts will discuss the role of mechanical circulatory support devices in these patients, as well as the diagnosis and treatment of microvascular angina, which can be a challenging complication...
Role of deferred stenting in culprit and non-culprit lesions for STEMI
14 May 2024 – From EuroPCR 2024
This session explores the role of deferred stenting in STEMI patients, covering when and how PCI can be deferred, the latest pharmacological options for deferred stenting, and the use of imaging and physiology to guide revascularization in a primary PCI setting. Through case presentations and discussions,...
What about MINOCA?
14 May 2024 – From EuroPCR 2024
This session focuses on the topic of Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA). It covers the mechanisms underlying MINOCA, the criteria for its diagnosis, and the management of patients with this condition. The session provides insights from both the clinician's and the patient's perspectives, addressing...
How the latest recommendations on MINOCA can impact our practice
14 May 2024 – From EuroPCR 2024
Join Vijay Kunadian and Salvatore Brugaletta as they talk about the latest ESC guidelines for MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries). Together, they review the crucial aspects of identifying MINOCA patients, how to diagnose them effectively using available diagnostic tools and the importance of post-treatment...
When should we perform PCI for stable coronary artery disease in aortic stenosis, pre, post, never?
17 May 2023 – From EuroPCR 2023
What is the evidence for the need for PCI in patients with stable coronary artery disease and severe aortic stenosis? Is invasive angiography always mandatory for these patients? What about CT scans? When exactly should PCI be performed?
These are the questions Vijay Kunadian and Martine Gilard...
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
Valve-in-valve - LIVE case
21 Sep 2023 – From AICT-AsiaPCR 2023
An 84-year-old man, with a history of 23 Carpentier-Edwards in 2004, PPM in 2013, AF on warfarin and impaired LV function (40 %), presented with severe symptomatic stenosis of the surgical bioprosthesis.
A 23 Navitor was implanted without predilatation and with post-dilatation under cerebral protection (Sentinel).
Closure was...
2023 ESC Guidelines for the management of acute coronary syndromes
30 Aug 2023
Cardiovascular disease in particular ischaemic heart disease is the leading cause of mortality worldwide. International guidelines provide recommendations on the best evidence-based care for patients. At the ESC Congress 2023 in Amsterdam, the ESC 2023 Guidelines on Acute Coronary Syndromes were presented and published1. Vijay Kunadian provides...
Author
PCRonline @ ESC Congress 2023: the interventional cardiology perspective!
07 Aug 2023
What was new and hot in interventional cardiology at #ESCCongress 2023!
Strategic management of coronary artery disease and TAVI in patients with aortic stenosis
18 May 2023 – From EuroPCR 2023
This session offers the opportunity to explore the intricacies and nuances involved in the management of patients with aortic stenosis and coronary artery disease, providing valuable knowledge and practical insights. Gain a comprehensive understanding of the pre-operative and intra-operative aspects of TAVI through a series of...
Contemporary management of patients with INOCA: a practical guide
17 May 2023 – From EuroPCR 2023
Enrich your understanding of ischemia with non-obstructive corona arteries (INOCA) by watching this very practical session, where you'll discover precious knowledge on the prevalence and causative factors of this condition. Dive into the diagnosis algorithm used for INOCA and explore the latest advancements in its management.
